15 August 2018
15 August 2018 to 17 August 2018
A group of classicists in the Netherlands recently received a large (€ 18.8m) grant to study innovation processes in the ancient world, and specifically the difference between invention or novelty and successful (or, as the case might be, failed) uptake of the invention. Their program addresses a paradox presented by the classical world: on the one hand the ancient Greeks and Romans were great innovators in many fields (think e.g. of democracy, rational medicine and science or the arts); on the other hand, they always seemed to be looking backwards, revering their traditions and ancestors and adverse to novelty and revolution: they were “in the grip of the past” (Van Groningen). Modern studies have emphasized either the traditionalism of classical civilization or, conversely, its innovative character. The Dutch program starts from the assumption that, far from presenting an anomaly, these two sides really should be studied as hanging together. For an innovation to be acceptable and successful it needs to be anchored in the known and familiar. Hence the title of the program: ‘Anchoring Innovation.’
Our symposium is designed to learn about this project and see how its theoretical frame might be co-opted by early Christian studies and also refined by the new social and intellectual phenomena of Christianity, and the insights of theologians and historians of theology. A long-standing set of questions in patristic studies, of course, relates to how Christianity adapted ideas and forms of life from the surrounding Greco-Roman world. We hope that the emphasis on mechanisms of ‘anchoring’ might provide a useful framework to extend this scholarship and allow it to speak in new ways to other areas of the humanities.
The speakers for the symposium are as follows:
Download the Symposium program here (PDF file, 817KB)
We're available 9am–5pm AEDT,
Monday to Friday
If you’ve got a question, our AskACU team has you covered. You can search FAQs, text us, email, live chat, call – whatever works for you.